AAAAAA

   
Results: 1-25 | 26-43
Results: 1-25/43
IN-VITRO P24 ANTIGEN-STIMULATED LYMPHOCYTE-PROLIFERATION AND BETA-CHEMOKINE PRODUCTION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-SEROPOSITIVE SUBJECTS AFTER IMMUNIZATION WITH AN INACTIVATED GP120-DEPLETEDHIV-1 IMMUNOGEN (REMUNE)
Authors: MOSS RB WALLACE MR LANZA P GIERMAKOWSKA W JENSEN FC THEOFAN G CHAMBERLIN C RICHIERI SP CARLO DJ
Citation: Rb. Moss et al., IN-VITRO P24 ANTIGEN-STIMULATED LYMPHOCYTE-PROLIFERATION AND BETA-CHEMOKINE PRODUCTION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-SEROPOSITIVE SUBJECTS AFTER IMMUNIZATION WITH AN INACTIVATED GP120-DEPLETEDHIV-1 IMMUNOGEN (REMUNE), Clinical and diagnostic laboratory immunology, 5(3), 1998, pp. 308-312
A PHASE I II STUDY OF TGAAV-CF FOR THE TREATMENT OF CHRONIC SINUSITISIN PATIENTS WITH CYSTIC-FIBROSIS/
Authors: WAGNER JA MORAN ML MESSNER AH DAIFUKU R CONRAD CK REYNOLDS T GUGGINO WB MOSS RB CARTER BJ WINE JJ FLOTTE TR GARDNER P
Citation: Ja. Wagner et al., A PHASE I II STUDY OF TGAAV-CF FOR THE TREATMENT OF CHRONIC SINUSITISIN PATIENTS WITH CYSTIC-FIBROSIS/, Human gene therapy, 9(6), 1998, pp. 889-909
GETTING TO THE HAART OF THE MATTER - IMMUNE-RESPONSES AGAINST THE VIRUS
Authors: MOSS RB
Citation: Rb. Moss, GETTING TO THE HAART OF THE MATTER - IMMUNE-RESPONSES AGAINST THE VIRUS, AIDS research and human retroviruses, 14, 1998, pp. 133-134
A PRIMER ON HIV TYPE 1-SPECIFIC IMMUNE FUNCTION AND REMUNE(TM)
Authors: MOSS RB GIERMAKOWSKA WK SAVARY JR THEOFAN G DAIGLE AE RICHIERI SP JENSEN FC CARLO DJ
Citation: Rb. Moss et al., A PRIMER ON HIV TYPE 1-SPECIFIC IMMUNE FUNCTION AND REMUNE(TM), AIDS research and human retroviruses, 14, 1998, pp. 167-175
EFFECT OF HIV-SPECIFIC IMMUNE-BASED THERAPY IN SUBJECTS INFECTED WITHHIV-1 SUBTYPE-E IN THAILAND
Authors: CHURDBOONCHART V MOSS RB SIRAWARAPORN W SMUTHARAKS B SUTTHENT R JENSEN FC VACHARAK P GRIMES J THEOFAN G CARLO DJ
Citation: V. Churdboonchart et al., EFFECT OF HIV-SPECIFIC IMMUNE-BASED THERAPY IN SUBJECTS INFECTED WITHHIV-1 SUBTYPE-E IN THAILAND, AIDS, 12(12), 1998, pp. 1521-1527
WHOLE-KILLED GP120-DEPLETED HIV-1 ANTIGEN IN A MURINE MODEL FOR PROPHYLACTIC VACCINATION
Authors: LANZA P MOSS RB GIERMAKOWSKA W HANCOCK RB RICHIERI SP THEOFA G JENSEN FC SALK PL CARLO DJ
Citation: P. Lanza et al., WHOLE-KILLED GP120-DEPLETED HIV-1 ANTIGEN IN A MURINE MODEL FOR PROPHYLACTIC VACCINATION, Vaccine, 16(7), 1998, pp. 727-731
SAFETY AND IMMUNOGENICITY OF REMUNE(TM) IN HIV-INFECTED THAI SUBJECTS
Authors: LIMSUWAN A CHURDBOONCHART V MOSS RB SIRAWARAPORN W SUTTHENT R SMUTHARAKS B GLIDDEN D TRAUGER R THEOFAN G CARLO D
Citation: A. Limsuwan et al., SAFETY AND IMMUNOGENICITY OF REMUNE(TM) IN HIV-INFECTED THAI SUBJECTS, Vaccine, 16(2-3), 1998, pp. 142-149
EFFICIENT AND PERSISTENT GENE-TRANSFER OF AAV-CFTR IN MAXILLARY SINUS
Authors: WAGNER JA REYNOLDS T MORAN ML MOSS RB WINE JJ FLOTTE TR GARDNER P
Citation: Ja. Wagner et al., EFFICIENT AND PERSISTENT GENE-TRANSFER OF AAV-CFTR IN MAXILLARY SINUS, Lancet, 351(9117), 1998, pp. 1702-1703
BONE ACQUISITION AND LOSS IN CHILDREN AND ADULTS WITH CYSTIC-FIBROSIS- A LONGITUDINAL-STUDY
Authors: BHUDHIKANOK GS WANG MC MARCUS R HARKINS A MOSS RB BACHRACH LK
Citation: Gs. Bhudhikanok et al., BONE ACQUISITION AND LOSS IN CHILDREN AND ADULTS WITH CYSTIC-FIBROSIS- A LONGITUDINAL-STUDY, The Journal of pediatrics, 133(1), 1998, pp. 18-27
EFFECT OF IMMUNIZATION WITH AN INACTIVATED GP120-DEPLETED HIV-1 IMMUNOGEN ON BETA-CHEMOKINE AND CYTOKINE PRODUCTION IN SUBJECTS WITH HIV-1 INFECTION
Authors: MOSS RB TRAUGER RJ GIERMAKOWSKA WK TURNER JL WALLACE MR JENSEN FC RICHIERI SP FERRE F DAIGLE AE DUFFY C THEOFAN G CARLO DJ
Citation: Rb. Moss et al., EFFECT OF IMMUNIZATION WITH AN INACTIVATED GP120-DEPLETED HIV-1 IMMUNOGEN ON BETA-CHEMOKINE AND CYTOKINE PRODUCTION IN SUBJECTS WITH HIV-1 INFECTION, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 343-350
HIV-1-SPECIFIC FUNCTIONAL IMMUNE MEASUREMENTS AS MARKERS OF DISEASE PROGRESSION
Authors: MOSS RB RICHIERI SP FERRE F DAIGLE AE TRAUGER R THEOFAN G GIERMAKOWSKA W LANZA P BROSTOFF S CARLO DJ JENSEN FC
Citation: Rb. Moss et al., HIV-1-SPECIFIC FUNCTIONAL IMMUNE MEASUREMENTS AS MARKERS OF DISEASE PROGRESSION, Journal of biomedical science, 4(4), 1997, pp. 127-131
CONSTITUTIVE MESSENGER-RNA AND IMMUNOREACTIVITY FOR IL-2 IN HUMAN NASAL-MUCOSA
Authors: MOSS RB NAGATA H GOFF J OKUBO K HAUSEFELD J KALINER MA
Citation: Rb. Moss et al., CONSTITUTIVE MESSENGER-RNA AND IMMUNOREACTIVITY FOR IL-2 IN HUMAN NASAL-MUCOSA, Clinical and experimental allergy, 27(4), 1997, pp. 406-412
CROSS-CLADE IMMUNE-RESPONSES AFTER IMMUNIZATION WITH A WHOLE-KILLED GP120-DEPLETED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IMMUNOGEN IN INCOMPLETE FREUNDS-ADJUVANT (HIV-1 IMMUNOGEN, REMUNE(TM)) IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEROPOSITIVE SUBJECTS
Authors: MOSS RB GIERMAKOWSKA W LANZA P TURNER JL WALLACE MR JENSEN FC THEOFAN G RICHIERI SP CARLO DJ
Citation: Rb. Moss et al., CROSS-CLADE IMMUNE-RESPONSES AFTER IMMUNIZATION WITH A WHOLE-KILLED GP120-DEPLETED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IMMUNOGEN IN INCOMPLETE FREUNDS-ADJUVANT (HIV-1 IMMUNOGEN, REMUNE(TM)) IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEROPOSITIVE SUBJECTS, Viral immunology, 10(4), 1997, pp. 221-228
EFFECT OF IMMUNIZATION WITH AN INACTIVATED GP120 DEPLETED HIV-1 IMMUNOGEN (REMUNE(TM) ON BETA-CHEMOKINE AND CYTOKINE PRODUCTION IN SUBJECTSWITH HIV-1 INFECTION
Authors: MOSS RB TRAUGER RJ GIERMAKOWSKA WK TURNER JL WALLACE MR RICHIERI SP FERRE F DAIGLE AE DUFFY C THEOFAN G CARLO DJ JENSEN FC
Citation: Rb. Moss et al., EFFECT OF IMMUNIZATION WITH AN INACTIVATED GP120 DEPLETED HIV-1 IMMUNOGEN (REMUNE(TM) ON BETA-CHEMOKINE AND CYTOKINE PRODUCTION IN SUBJECTSWITH HIV-1 INFECTION, Journal of allergy and clinical immunology, 99(1), 1997, pp. 193-193
REDUCED IL-10 SECRETION BY T-CELLS EXPRESSING MUTANT CFTR - A ROLE FOR CA2- CHANNELS( AND CL)
Authors: MOSS RB HSU Y OLDS L
Citation: Rb. Moss et al., REDUCED IL-10 SECRETION BY T-CELLS EXPRESSING MUTANT CFTR - A ROLE FOR CA2- CHANNELS( AND CL), Journal of allergy and clinical immunology, 99(1), 1997, pp. 1347-1347
CYSTIC-FIBROSIS - EVALUATION OF A THIN-SECTION CT SCORING SYSTEM
Authors: ROBINSON T LEUNG AN MOSS RB BLOCH DA NORTHWAY WH
Citation: T. Robinson et al., CYSTIC-FIBROSIS - EVALUATION OF A THIN-SECTION CT SCORING SYSTEM, Radiology, 205, 1997, pp. 660-660
ACTIVATION OF EOSINOPHILS IN THE AIRWAYS OF LUNG TRANSPLANTATION PATIENTS
Authors: DOSANJH AK ELASHOFF D KAWALEK A MOSS RB ESRIG S
Citation: Ak. Dosanjh et al., ACTIVATION OF EOSINOPHILS IN THE AIRWAYS OF LUNG TRANSPLANTATION PATIENTS, Chest, 112(5), 1997, pp. 1180-1183
EARLY CLINICAL MARKERS AND CD4 PERCENTAGE IN SUBJECTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: WALLACE MR MOSS RB BEECHMAN HJ GRACE CJ HERSH EM PETERSON E MURPHY R SHEPP DH SIEGAL FP TURNER JL SAFRIN S CARLO DJ LEVINE AM
Citation: Mr. Wallace et al., EARLY CLINICAL MARKERS AND CD4 PERCENTAGE IN SUBJECTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Journal of acquired immune deficiency syndromes and human retrovirology, 12(4), 1996, pp. 358-362
COMBINATION THERAPIES AGAINST HIV-1 INFECTION - EXPLORING THE CONCEPTOF COMBINING ANTIRETROVIRAL DRUG TREATMENTS WITH HIV-1 IMMUNE-BASED THERAPIES IN ASYMPTOMATIC INDIVIDUALS
Authors: FERRE F MOSS RB DAIGLE AE TRAUGER RJ RICHIERI SP JENSEN FC CARLO DJ
Citation: F. Ferre et al., COMBINATION THERAPIES AGAINST HIV-1 INFECTION - EXPLORING THE CONCEPTOF COMBINING ANTIRETROVIRAL DRUG TREATMENTS WITH HIV-1 IMMUNE-BASED THERAPIES IN ASYMPTOMATIC INDIVIDUALS, AIDS patient care, 10(6), 1996, pp. 357-361
CELLULAR-IMMUNITY TO HIV ANTIGENS IN HIV-INFECTED INDIVIDUALS AND IN SERONEGATIVE, EXPOSED HEALTH-CARE WORKERS
Authors: PINTO LA STAKE J LANDAY AL BERZOFSKY JA MOSS RB CLERICI M KESSLER HA SHEARER GM
Citation: La. Pinto et al., CELLULAR-IMMUNITY TO HIV ANTIGENS IN HIV-INFECTED INDIVIDUALS AND IN SERONEGATIVE, EXPOSED HEALTH-CARE WORKERS, The FASEB journal, 10(6), 1996, pp. 355-355
NASAL MUCOSAL CELLS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-SEROPOSITIVE PATIENTS WITH SINUSITIS
Authors: MOSS RB SCOTT TA GOLDRICH M PITALE M DANIEL A LEBOVICS R WALKER R IGARASHI Y KALINER MA
Citation: Rb. Moss et al., NASAL MUCOSAL CELLS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-SEROPOSITIVE PATIENTS WITH SINUSITIS, Journal of clinical laboratory analysis, 10(6), 1996, pp. 418-422
VIRAL LOAD, CD4 PERCENTAGE, AND DELAYED-TYPE HYPERSENSITIVITY IN SUBJECTS RECEIVING THE HIV-1 IMMUNOGEN AND ANTIVIRAL DRUG-THERAPY
Authors: MOSS RB FERRE F LEVINE A TURNER J JENSEN FC DAIGLE AE RICHIERI SP TRUCKENBROD A TRAUGER RJ CARLO DJ SALK J
Citation: Rb. Moss et al., VIRAL LOAD, CD4 PERCENTAGE, AND DELAYED-TYPE HYPERSENSITIVITY IN SUBJECTS RECEIVING THE HIV-1 IMMUNOGEN AND ANTIVIRAL DRUG-THERAPY, Journal of clinical immunology, 16(5), 1996, pp. 266-271
CORRELATES OF OSTEOPENIA IN PATIENTS WITH CYSTIC-FIBROSIS
Authors: BHUDHIKANOK GS LIM J MARCUS R HARKINS A MOSS RB BACHRACH LK
Citation: Gs. Bhudhikanok et al., CORRELATES OF OSTEOPENIA IN PATIENTS WITH CYSTIC-FIBROSIS, Pediatrics, 97(1), 1996, pp. 103-111
CLINICAL PROTOCOL - AAV-CFTR FOR THE TREATMENT OF CHRONIC SINUSITIS IN CF PATIENTS
Authors: WAGNER JA MORAN ML KOUYAMA K MOSS RB WINE JJ GARDNER P
Citation: Ja. Wagner et al., CLINICAL PROTOCOL - AAV-CFTR FOR THE TREATMENT OF CHRONIC SINUSITIS IN CF PATIENTS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 63-63
REDUCED IL-10 SECRETION BY CD4(-LYMPHOCYTES EXPRESSING MUTANT CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR)() T)
Authors: MOSS RB BOCIAN RC HSU YP DONG YJ KEMNA M WEI T GARDNER P
Citation: Rb. Moss et al., REDUCED IL-10 SECRETION BY CD4(-LYMPHOCYTES EXPRESSING MUTANT CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR)() T), Clinical and experimental immunology, 106(2), 1996, pp. 374-388
Risultati: 1-25 | 26-43